Last reviewed · How we verify
NCT06375850
Effects of Topical Sesame Oil in the Prevention of Peripheral Venous Catheter Phlebitis: Clinical Trial.
NA trial testing Sesame oil in Phlebitis in 300 participants. Currently enrolling.
11 February 2025
Quick facts
| Lead sponsor | Hospital Universitario Marqués de Valdecilla |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 300 |
| Start date | 5 June 2022 |
| Primary completion | 11 February 2025 |
| Estimated completion | 11 May 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Sesame oil — full drug profile →
- Saline solution
Conditions studied
- Phlebitis — all drugs for Phlebitis →
Sponsor
Hospital Universitario Marqués de Valdecilla
Who can join
18 and older, any sex, with Phlebitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cancer is a disease that, despite having a higher cure rate, is currently on the rise, with an increase in the number of diagnoses. For the treatment of these patients a venous access is required, which in the first treatments is of peripheral insertion. These peripheral venous catheter in combination with the highly aggressive treatments for the veins are the cause of the appearance of chemical phlebitis. Phlebitis is an inflammation caused by a combination of factors, whether chemical, perfusion of irritating medication; mechanical, due to the puncture site, type and fixation of the catheter and infectious, caused by the colonization of pathogenic agents whose origin is the skin and that migrate inward. Phlebitis involves an injury to the wall of the vein, and consequently, the patient will also be at risk of thrombus formation, which in turn leads to thrombophlebitis, deep vein thrombosis or pulmonary embolism. The existence of phlebitis involves intense and constant pain, with increased sensitivity and a sensation of heat and swelling. With the use of topical sesame oil, and thanks to its anti-inflammatory properties, the investigators intend to study whether it is effective in preventing the appearance of phlebitis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06375850
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Sesame oil
Trials testing the same drug.
- NCT06151769 — The Effect Pomegranate Seed Oil Prevention and Progression Pressure Ulcers in Intensive Care Patients · NA · unknown
Other recruiting trials for Phlebitis
Currently open trials in the same condition.
- NCT06770374 — Effectiveness of a Zinc Oxide Adhesive Securement Device in the Fixation of Midline and Peripherally Inserted Central Ca · NA · recruiting
Other Hospital Universitario Marqués de Valdecilla trials
Trials by the same sponsor.
- NCT06102993 — Ferroptosis in Patients With COPD COPD With/Without Risk of Cardiovascular Events. Pathophysiological Implications, Diag · unknown
- NCT05855616 — Chlorhexidine Dressings for Hemodialysis Catheter Exit Site Care: Comparative Study · NA · completed
- NCT04449419 — Mitoquines in COPD · unknown
- NCT03936231 — Cross-sectional, Observational, Prospective and Analytical Study:MECHANICAL POWER DAY (MPDay) · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06375850 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Universitario Marqués de Valdecilla
- Last refreshed: 19 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06375850.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing